Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Xevudy 500 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
sotrovimab
Company:  
GlaxoSmithKline UK See contact details
ATC code: 
J06BD05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Xevudy®▼(sotrovimab) 500 mg concentrate for solution for infusion: Important information for healthcare professionals about the expiry date of all packs

This DHCPL details a further shelf life extension to 42 months for specified batches of Xevudy (sotrovimab) 500 mg concentrate for solution for infusion, in the UK(GB) market.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

GlaxoSmithKline UK
Company image
Address
79 New Oxford Street, London, WC1A 1DG, UK
Telephone
0800 221 441
Medical Information e-mail
[email protected]
E-mail
[email protected]
Adverse event reporting email
[email protected]